1-500 | 501-846
    Part,  Chapter, Paragraph

  1    -,     1            |               have been published:~a) in 2003, “The Health Status of the
  2    I,     2.  2        |              turned negative in 2001 and 2003 they continued growing in
  3    I,     2.  5        |               published in early October 2003, presented a panorama of
  4    I,     2.  6        |                  ISCED levels 5 or 6) in 2003/2004~ ~This gap is evident
  5    I,     2.  6        |            increased between 1997/98 and 2003/04 in virtually all countries
  6    I,     2.  6        |                almost 47% of students in 2003-04. In Belgium and the Czech Republic
  7    I,     2.  6        |             Iceland. Between 1997/98 and 2003/04, the number of women
  8    I,     2.  6        |                91.6 millions in 2002 and 2003 respectively to 71.7 millions
  9    I,     2.  7        |                 NMS or Turkey (EUROSTAT, 2003). EURIPA, the European Rural
 10    I,     2.  9        |                  e.g. the summer heat of 2003 and the spring drought of
 11    I,     2. 10.  4    |                 dispensing system in May 2003. A study in the hospital
 12    I,     2. 11        |           Available at: ftp ~ ~EUROSTAT (2003): Eurostat yearbook 2003,
 13    I,     2. 11        |                 2003): Eurostat yearbook 2003, the statistical guide to
 14    I,     2. 11        |                 yearbook 2005. Data 1999-2003. [on-line publication available
 15   II,     4.  1        |                   Jagger and Euro-REVES, 2003; Robine et al, 2003).~ ~
 16   II,     4.  1        |          Euro-REVES, 2003; Robine et al, 2003).~ ~Following the adoption
 17   II,     4.  1        |                   Jagger and Euro-REVES, 2003) and is to be a subset of
 18   II,     4.  1        |                   Jagger and Euro-REVES, 2003). All data (death counts,
 19   II,     4.  1        |              expectancies (Robine et al, 2003), on both sides of the North
 20   II,     4.  3        |                   M., C. Jagger, et al. (2003): Creating a coherent set
 21   II,     4.  3        |                 C. Jagger, et al., Eds. (2003): Determining health expectancies.
 22   II,     4.  3        |                and the Euro-REVES Group (2003): Creating a coherent set
 23   II,     4.  3        |                 Journal of Public Health 2003; 13:6-14.~ ~Robine, J.-M.,
 24   II,     5.  1.  1    |             death; 3 years average (2001-2003), EU27 – A) Women~ ~Figure
 25   II,     5.  1.  1    |             death; 3 years average (2001-2003), EU27B) Men.~ ~ ~ ~Table
 26   II,     5.  1.  1    |               HPV (Stewart and Kleihues, 2003). Genital HPV is usually
 27   II,     5.  1.  1    |              race (Stewart and Kleihues, 2003).~ ~Other types of cancer:
 28   II,     5.  1.  1    |                COPD.A study by Lundback (2003) showed that age and smoking
 29   II,     5.  2.  2    |                  3 years available (2001-2003) in the European Union (
 30   II,     5.  2.  2    |                 the last ten years (1994-2003) to estimate trends. Thus,
 31   II,     5.  2.  2    |               the three year period 2001-2003 along with those already
 32   II,     5.  2.  2    |                 the last year available (2003) are reported. Other data,
 33   II,     5.  2.  2    |                 The last ten years (1994-2003) were selected to estimate
 34   II,     5.  2.  2    |                 the last year available (2003) are reported.~The ICD morbidity
 35   II,     5.  2.  3    |               the most recent data (2001-2003), the rates vary from 42.
 36   II,     5.  2.  3    |               all countries from 1994 to 2003 mortality rates in the 35-
 37   II,     5.  2.  3    |                  Eurociss Working Group, 2003).~ ~Table 5.2.4. WHO-MONICA
 38   II,     5.  2.  3    |               Figure 5.2.3; from 1994 to 2003 mortality rates in the age
 39   II,     5.  2.  3    |                  to 357 per 100.000). In 2003, mortality rates in Central
 40   II,     5.  2.  3    |                  to 246 per 100.000). In 2003, mortality rates in Southern
 41   II,     5.  2.  3    |           disease severity (Sarti et al, 2003).~ ~Table 5.2.6. WHO-MONICA
 42   II,     5.  2.  5    |                factors (Greenland et al, 2003), and optimal levels of
 43   II,     5.  2.  6    |           significant (Turnbull S et al, 2003). Lifestyle improvement
 44   II,     5.  2.  6    |                Trialists' Collaboration (2003). Effects of different blood-pressure-lowering
 45   II,     5.  2.  7    |            EUROCISS Project final report 2003 updated May 2006 [htt ] (
 46   II,     5.  2.  7    |                  EUROCISS Working Group (2003): Coronary and cerebrovascular
 47   II,     5.  2.  7    |              Garside DB, and. Wilson PW (2003): Major risk factors as
 48   II,     5.  2.  7    |                  the WHO MONICA Project (2003): Are changes in mortality
 49   II,     5.  3.  1    |                 in the near future (WHO, 2003; Micheli, Baili et al, 2003).~ ~
 50   II,     5.  3.  1    |              2003; Micheli, Baili et al, 2003).~ ~Main indicators to describe
 51   II,     5.  3.  1    |               Micheli, Capocaccia et al, 2003), in this chapter cancer
 52   II,     5.  3.  2    |               project (Capocaccia et al, 2003; Sant et al, 2003; Berrino
 53   II,     5.  3.  2    |                 et al, 2003; Sant et al, 2003; Berrino et al, 2007)~ ~·
 54   II,     5.  3.  3    |            EUROCARE project (Sant et al, 2003; Berrino et al, 2007; Verdecchia
 55   II,     5.  3.  4    |               HPV (Stewart and Kleihues, 2003). Genital HPV is usually
 56   II,     5.  3.  4    |              race (Stewart and Kleihues, 2003).~ ~
 57   II,     5.  3.  5    |         infection (Stewart and Kleihues, 2003). Cervical cancer incidence
 58   II,     5.  3.  6    |              Eastern Europe (Sant et al, 2003).~ ~Figure 5.3.29a. All
 59   II,     5.  3.  6    |    post-operative mortality (Sant et al, 2003).~ ~Figure 5.3.30a. Stomach
 60   II,     5.  3.  6    |                cancer sites (Sant et al, 2003).~ ~Figure 5.3.31a. Colorectal
 61   II,     5.  3.  6    |                 8% in women (Sant et al, 2003).~ ~Figure 5.3.32a. Lung
 62   II,     5.  3.  6    |                  60 and 67% (Sant et al, 2003).~Relative survival for
 63   II,     5.  3.  6    |                increased (Coleman et al, 2003).~ ~Figure 5.3.33. Female
 64   II,     5.  3.  6    |              Figure 5.3.34) (Sant et al, 2003). Survival has improved
 65   II,     5.  3.  6    |                treatment (Coleman et al, 2003).~ ~Figure 5.3.34. Cervical
 66   II,     5.  3.  6    |             survival (<55%) (Sant et al, 2003). European 5-year relative
 67   II,     5.  3.  6    |            incidence levels (Sant et al, 2003; Coleman et al, 2003).~ ~
 68   II,     5.  3.  6    |                 al, 2003; Coleman et al, 2003).~ ~Figure 5.3.35. Prostate
 69   II,     5.  3.  6    |                 followed up to December, 2003.~Age-adjusted 5-year relative
 70   II,     5.  3.  7    |             strategies and actions (WHO, 2003). The first phase to plan
 71   II,     5.  3.  7    |               are all recommended by the 2003 European Code Against Cancer
 72   II,     5.  3.  7    |                the disease (Boyle et al, 2003).~ ~See Chapter 10 for primary
 73   II,     5.  3.  7    |                for colorectal cancer. In 2003 the European Council published
 74   II,     5.  3.  7    |            programmes (European Council, 2003). Recommendations referred
 75   II,     5.  3.  7    |              health care (Coleman et al, 2003).~Estimating the range of
 76   II,     5.  3.  7    |              health care (Coleman et al, 2003). Therefore, it is fundamental
 77   II,     5.  3.  7    |                stage~CZECH REPUBLIC~Yes (2003)~DENMARK~Yes~GERMANY~No~
 78   II,     5.  3.  8    |             recent years (Coleman et al, 2003). Cancer prevalence, the
 79   II,     5.  3.  9    |            Autier P, Bartelink H, et al (2003): European Code Against
 80   II,     5.  3.  9    |                  EUROCARE Working Group (2003): EUROCARE-3 summary. Cancer
 81   II,     5.  3.  9    |               2008).~ ~European Council (2003): Council recommendation
 82   II,     5.  3.  9    |             recommendation of 2 December 2003 on cancer screening. htt f (
 83   II,     5.  3.  9    |                  EUROCARE Working Group (2003): Life expectancy and cancer
 84   II,     5.  3.  9    |                 A, Berrino F, Coleman M (2003): Cancer control in Europe:
 85   II,     5.  3.  9    |                  EUROCARE Working Group (2003): EUROCARE-3: survival of
 86   II,     5.  3.  9    |                  Stewart BW, Kleihues P (2003): World Cancer Report. WHO
 87   II,     5.  3.  9    |              Washington DC: AICR.~ ~WHO (2003): Strategies to improve
 88   II,     5.  4.  2    |                   Gudbjörnsdottir et al. 2003) and Denmark (Carstersen
 89   II,     5.  4.  6    |              national basis (de Beaufort 2003). The final report, published
 90   II,     5.  4.  6    |             adequate treatments. The WHO 2003 report defines screening
 91   II,     5.  4.  8    |            October 2008)~De Beaufort CE (2003): European Union diabetes
 92   II,     5.  4.  8    |              National Diabetes Register (2003), The National Diabetes
 93   II,     5.  4.  8    |             Diabetes Care.Diabetes Care. 2003 Apr;26(4):1270-6.~Greenfield
 94   II,     5.  5.Int    |             problem (European Commission 2003), which range from mild
 95   II,     5.  5.Int    |             policy initiatives20. The EU 2003-2008 Public Health Programme
 96   II,     5.  5.Int    |              People with Disabilities in 2003; and (iii) The adoption
 97   II,     5.  5.  1    |             Fryers, 2007, Blakely et al, 2003) although there are other
 98   II,     5.  5.  1    |           individual (e.g. Blakely et al 2003) and even at community level (
 99   II,     5.  5.  1    |              Violence Epidemiology (1999-2003), evaluated the quality
100   II,     5.  5.  1    |                 Collings SC, Atkinson J (2003). Unemployment and suicide.
101   II,     5.  5.  3    |              body characteristics” (WHO, 2003).~Eating disorders such
102   II,     5.  5.  3    |               2007; Hoek and van Hoeken, 2003).~ ~Reviewed articles and
103   II,     5.  5.  3    |                  by Hoek and van Hoeken (2003) for several Western and
104   II,     5.  5.  3    |                  by Hoek and van Hoeken (2003) for several Western and
105   II,     5.  5.  3    |                low (Hoek and van Hoeken, 2003). An average prevalence
106   II,     5.  5.  3    |             rising (Hoek and van Hoeken, 2003). Time trends in incidence
107   II,     5.  5.  3    |               1990 (Hoek and van Hoeken, 2003). Hoek and van Hoeken (2003)
108   II,     5.  5.  3    |              2003). Hoek and van Hoeken (2003) reported a significant
109   II,     5.  5.  3    |                000 (Hoek and van Hoeken, 2003).~The HBSC (Health Behaviour
110   II,     5.  5.  3    |                 Hoek H W, van Hoeken D, (2003): Review of the Prevalence
111   II,     5.  5.  3    |               Health Organization (WHO) (2003): Eating disorders. National
112   II,     5.  5.  3    |                treatments (Lehman et al, 2003). Apart from the inadequacy
113   II,     5.  5.  3    |               between July 2002 and June 2003 substantiate that only 30%
114   II,     5.  5.  3    |                  with schizophrenia (IMS 2003).~ ~ ~Health indicators
115   II,     5.  5.  3    |                  well it works (Spollen, 2003).~Domains reflecting this
116   II,     5.  5.  3    |               2007; Vauth, 2006,; Glynn, 2003; Pilling et al, 2002) –
117   II,     5.  5.  3    |                   Lehman and Steinwachs, 2003). The latter is in part
118   II,     5.  5.  3    |               2005; AGREE Collaboration, 2003) – see table 5.5.3.2.4.~
119   II,     5.  5.  3    |            schizophrenia (Andrews et al, 2003). Their findings22% of
120   II,     5.  5.  3    |                 desirable (Wölwer et al, 2003)~Prevention~The WHO Report “
121   II,     5.  5.  3    |          References~AGREE Collaboration (2003): Development and validation
122   II,     5.  5.  3    |                  Issakidis C, Lapsley H (2003): Cost-effectiveness of
123   II,     5.  5.  3    |                  187: 248-255.~Glynn SM (2003): Psychiatric rehabilitation
124   II,     5.  5.  3    |      Psychopathology 35:36-47~Lehman AF (2003): Overview of best practices:
125   II,     5.  5.  3    |                Lehman AF, Steinwachs DM (2003): Evidence-based psychosocial
126   II,     5.  5.  3    |        Psychiatry 153:214-7.~Spollen JJ (2003): The efficacy-effectiveness
127   II,     5.  5.  3    |                  W, Möller HJ, Gaebel W (2003): German Research Network
128   II,     5.  5.  3    |           Spectrum Disorders in Spain in 2003. Journal of Autism and Development
129   II,     5.  5.  3    |        examination~396 ~5.3 ~Oun et al., 2003 (*)~Finland~Adults ~MR review
130   II,     5.  5.  3    |                  69 ~4.3 ~Tidman et al., 2003 (*)~+ = 5-14 years - = 6-
131   II,     5.  5.  3    |           reached 39% (Vignatelli et al, 2003). Although the idiosyncratic
132   II,     5.  5.  3    |                per 1,000 (Nilsson et al, 2003). There is some indication
133   II,     5.  5.  3    |                 difficulties (Anonymous, 2003). An old study made on the
134   II,     5.  5.  3    |               Western Europe (Anonymous, 2003). These findings are in
135   II,     5.  5.  3    |             could understand (Anonymous, 2003). The ILAE Employment Commission
136   II,     5.  5.  3    |               state agencies (Anonymous, 2003). The elements of these
137   II,     5.  5.  3    |                  References~ ~Anonymous (2003): Living with epilepsy.
138   II,     5.  5.  3    |                  Farahmand BY, Tomson T (2003): Mortality in a population-based
139   II,     5.  5.  3    |               results from meta-analysis 2003. Report to the Institute
140   II,     5.  5.  3    |             Study of Status Epilepticus (2003): Incidence and short-term
141   II,     5.  5.  3    |                  Confavreux et al, 2000; 2003).~ ~The Norwegian National
142   II,     5.  5.  3    |             County prevalence was 151 in 2003. In most Nordic counties
143   II,     5.  5.  3    |             considered (Zivadinov et al, 2003). However, for prevalence
144   II,     5.  5.  3    |               European Union~In December 2003 the European Parliament
145   II,     5.  5.  3    |                   Vukusic S, Adeleine P (2003): Early clinical predictors
146   II,     5.  5.  3    |                 Maltezos ES, Milonas IA (2003): Epidemiological data of
147   II,     5.  5.  3    |             Perini P, Tzintzeva E et al (2003): Increasing frequency of
148   II,     5.  5.  3    |                PJ, Hakama M, Wikström J (2003): Multiple sclerosis in
149   II,     5.  5.  3    |                   Nyström L, Forsgren L (2003): Incidence (1988-97): and
150   II,     5.  5.  3    |                 Monti-Bragadin L, et al (2003): The use of standardized
151   II,     5.  5.  3    |              studies (Benito-Leon et al, 2003; Bergareche et al, 2004;
152   II,     5.  5.  3    |                  disease (Findley et al, 2003; Spottke et al, 2005). A
153   II,     5.  5.  3    |                in detail (Twelves et al, 2003). Methodological differences
154   II,     5.  5.  3    |                Logroscino, 2005; Tanner, 2003; Tanner and Aston, 2000).~
155   II,     5.  5.  3    |                   Gabriel R, Morales JM (2003): Prevalence of PD and other
156   II,     5.  5.  3    |                  DG, Peto V, Playfer JR (2003): Direct economic impact
157   II,     5.  5.  3    |                   Giuffrida S, Reggio A (2003): Prevalence of Parkinson’
158   II,     5.  5.  3    |                13(4):427-430.~Tanner CM (2003): Is the cause of Parkinson’
159   II,     5.  5.  3    |                  Perkins KS, Counsell C (2003): Systematic review of incidence
160   II,     5.  6.  2    |             Start Of The New Millennium. 2003 WHO Technical Report Series
161   II,     5.  6.  2    |               and Bone and Joint Decade, 2003 (European Commission (2003):
162   II,     5.  6.  2    |               2003 (European Commission (2003): Indicators for Monitoring
163   II,     5.  6.  3    |                  North America (Symmons, 2003) are given in table 5.6.
164   II,     5.  6.  3    |               prevalence (Symmons et al, 2003). For example, a study of
165   II,     5.  6.  3    |         attributed to OA (Symmons et al, 2003).~ ~Table 5.6.2. Osteoarthritis
166   II,     5.  6.  3    |        procedures / 100,000 (Merx et al, 2003). The estimated requirement
167   II,     5.  6.  3    |                knee disease (Juni et al, 2003).~ ~Future trends~ ~Future
168   II,     5.  6.  3    |           criteria (European Commission (2003): Indicators for Monitoring
169   II,     5.  6.  3    |              scapula (Woolf and Pfleger, 2003).~ ~
170   II,     5.  6.  3    |                WHO Technical Report 919, 2003). There is a steep increase
171   II,     5.  6.  3    |             fracture (Woolf and Akesson, 2003).~ ~Most hip fractures occur
172   II,     5.  6.  3    |                 prior functions (Melton, 2003; Sernbo and Johnell, 1993).
173   II,     5.  6.  3    |                  33% (Woolf and Pfleger, 2003).~ ~Determinants, risk factors
174   II,     5.  6.  3    |               months (Woolf and Pfleger, 2003), but the longer on sick leave,
175   II,     5.  6.  4    |              1994. (European Commission (2003): Indicators for Monitoring
176   II,     5.  6.  4    |                     European Commission (2003): Indicators for Monitoring
177   II,     5.  6.  6    |                     European Commission (2003): Indicators for Monitoring
178   II,     5.  6.  6    |                  Greenwood R, Frankel S (2003): Population Requirement
179   II,     5.  6.  6    |                pp 225-47~Melton LJ, III (2003): Adverse outcomes of osteoporotic
180   II,     5.  6.  6    |                   Gunther KP, Brenner H (2003): International Variation
181   II,     5.  6.  6    |                760~Picavet HS, Hazes JM (2003): Prevalence of self reported
182   II,     5.  6.  6    |                Mathers C, and Pfleger B (2003): Global Burden of Osteoarthritis
183   II,     5.  6.  6    |               Health Organization~ ~WHO (2003): The Burden of Musculoskeletal
184   II,     5.  6.  6    |           Elsevier,~Woolf AD, Akesson K (2003): Preventing fractures in
185   II,     5.  6.  6    |                  Woolf AD and Pfleger B (2003): Burden of Major Musculoskeletal
186   II,     5.  7.  1    |                 al, 2005; Chadban et al, 2003) indicate the problem is
187   II,     5.  7.  1    |          complications (Chobanian et al, 2003; National Kidney Foundation,
188   II,     5.  7.  1    |                2002-2006; Sarnak et al., 2003; American Diabetes Association,
189   II,     5.  7.  1    |                multiplier (Sarnak et al. 2003). Furthermore, evidence
190   II,     5.  7.  1    |        microalbuminuria (Boulware et al, 2003; Gansevoort et al, 2005)
191   II,     5.  7.  1    |                is rare (Ardissino et al, 2003; Esbjorner et al, 1997).
192   II,     5.  7.  3    |        hypertensive ESRD (Stengel et al, 2003; van Dijk et al, 2005) After
193   II,     5.  7.  3    |                areas (UK Renal Registry, 2003).~ ~Prevalence~ ~For the
194   II,     5.  7.  3    |                  sub-optimal (Lin et al, 2003).~ ~Children and adolescents~ ~
195   II,     5.  7.  3    |            Chadha, 2007; Ardissino et al 2003). Data in a population-based
196   II,     5.  7.  3    |                  pmarp (Ardissino et al, 2003). In a survey in Sweden
197   II,     5.  7.  3    |                Report UK Renal Registry, 2003; Warady and Chadha, 2007;
198   II,     5.  7.  3    |                  sub-optimal (Lin et al, 2003).~ ~Although there are considerable
199   II,     5.  7.  3    |        hypertensive ESRD (Stengel et al, 2003; van Dijk et al, 2005) After
200   II,     5.  7.  4    |             Registry (UK Renal Registry, 2003), the prevalence of RRT
201   II,     5.  7.  5    |          cost-effective (Boulware et al, 2003; Atthobari et al, 2006).
202   II,     5.  7.  7    |       Claris-Appiani A, Taioli E, et al (2003): Epidemiology of chronic
203   II,     5.  7.  7    |              ItalKid project. Pediatrics 2003 Apr;111(4 Pt 1):e382-e387.~
204   II,     5.  7.  7    |                ME, Brancati FL, Powe NR (2003): Screening for proteinuria
205   II,     5.  7.  7    |        cost-effectiveness analysis. JAMA 2003;290(23):3101-14.~Chadban
206   II,     5.  7.  7    |            Welborn TA, Zimmet PZ, et al (2003): Prevalence of kidney damage
207   II,     5.  7.  7    |                  study. J Am Soc Nephrol 2003;14(7 Suppl 2):S131-S138.~
208   II,     5.  7.  7    |                  EL, Hogan ML, Singh AK (2003): A comparison of prediction
209   II,     5.  7.  7    |                disease. J Am Soc Nephrol 2003 Oct;14(10):2573-80.~Loucks
210   II,     5.  7.  7    |                 disease. Am J Kidney Dis 2003;41(suppl 3):S1-S92.~National
211   II,     5.  7.  7    |                 disease. Am J Kidney Dis 2003;42(Suppl 3):S1-S202.~National
212   II,     5.  7.  7    |                 Prevention. Hypertension 2003;42(5):1050-65.~Seligman
213   II,     5.  7.  7    |             Dekker FW, Simpson K, et al (2003): Trends in the incidence
214   II,     5.  7.  7    |                  Nephrol Dial Transplant 2003 Sep;18(9):1824-33.~Stevens
215   II,     5.  8.  2    |         different entities (Fabbri et al 2003), epidemiologically, they
216   II,     5.  8.  3    |                 opinions (Halbert et al, 2003). Recently, a meta-analysis (
217   II,     5.  8.  3    |            European respiratory Society, 2003). In EU15, 41 300 lost work
218   II,     5.  8.  3    |            European Respiratory Society, 2003).~ ~ ~The total costs of
219   II,     5.  8.  4    |                     A study by Lundback (2003) showed that age and smoking
220   II,     5.  8.  4    |                to males) (Cerveri et al, 2003).~ ~COPD has been usually
221   II,     5.  8.  4    |            burden of COPD (Balmes et al, 2003). Dusty environments were
222   II,     5.  8.  5    |                screening (Gorecka et al, 2003). The results showed that
223   II,     5.  8.  5    |            European Respiratory Society, 2003). This publication includes
224   II,     5.  8.  7    |               American Thoracic Society (2003) American Thoracic Society
225   II,     5.  8.  7    |            Schwartz D, Toren K, Viegi G (2003): American Thoracic Society
226   II,     5.  8.  7    |                  A, Viegi G, de Marco R (2003): Chronic cough and phlegm
227   II,     5.  8.  7    |               young adults. Eur Respir J 2003; 22: 413-417.~ ~Chapman
228   II,     5.  8.  7    |             Negro R, Rossi A, Cerveri I (2003): The burden of COPD in
229   II,     5.  8.  7    |                  COPD survey. Respir Med 2003; 97: s43-50.~ ~De Marco
230   II,     5.  8.  7    |               Respiratory Society (ERS) (2003). Chronic Obstructive Pulmonary
231   II,     5.  8.  7    |             Ciaccia A, Saetta M, Papi A (2003): Differences in airway
232   II,     5.  8.  7    |                Am J Respir Crit Care Med 2003; 167: 418–424.~ ~Furhman
233   II,     5.  8.  7    |           Goljan-Geremek A, Zielinski J (2003): Diagnosis of airflow limitation
234   II,     5.  8.  7    |                 stop-smoking rate. Chest 2003; 123: 1916-1923.~ ~Gudmundsson
235   II,     5.  8.  7    |            Isonaka S, George D, Iqbal A (2003): Interpreting COPD prevalence
236   II,     5.  8.  7    |                 burden of disease? Chest 2003; 123: 1684-1692.~ ~Horton
237   II,     5.  8.  7    |                 AL, Walk JA, Soriano JB (2003): What do chronic obstructive
238   II,     5.  8.  7    |            coding analysis. Eur Respir J 2003; 22: 809-814.~ ~Jansson
239   II,     5.  8.  7    |                  Sandstrom T, Larsson K (2003): Obstructive Lung Disease
240   II,     5.  8.  7    |               Sweden Studies. Respir Med 2003; 97: 115122.~ ~MacNee W,
241   II,     5.  9.  1    |            western lifestyle (Kim et al, 2003).~ ~In addition to the economic
242   II,     5.  9.  2    |                 survey. Between 2002 and 2003, two age-groups of schoolchildren
243   II,     5.  9.  3    |                  2007), reported that in 2003 the prevalence of allergic
244   II,     5.  9.  3    |                   Lung Health in Europe, 2003 ERJ)~ ~According to the “
245   II,     5.  9.  3    |                  Europe Facts & Figures, 2003 ERJ). The burden of asthma
246   II,     5.  9.  3    |                   Lung Health in Europe, 2003).~ ~In a review of nine
247   II,     5.  9.  4    |                 still unclear (Custovic, 2003; Simpson , 2005; Erwin,
248   II,     5.  9.  4    |                Survey I data, (Bousquet, 2003). Adults aged 2044, living
249   II,     5.  9.  4    |            allergic contact eczema) from 2003 to 2006 in a population-based
250   II,     5.  9.  7    |                  1):585-92~ ~Bousquet J (2003): Allergic Rhinitis and
251   II,     5.  9.  7    |                  ARIA). Clin Exp All Rev 2003; 3:43-45~ ~Bo N (2006):
252   II,     5.  9.  7    |                BM, Simpson A, Hallam CL (2003): Current mite, cat, and
253   II,     5.  9.  7    |                  J Allergy Clin Immunol. 2003 Feb;111(2):402-7.~ ~De Marco
254   II,     5.  9.  7    |                    Kim DS, Drake-Lee AB (2003). Infection, allergy and
255   II,     5.  9.  7    |                   Lung Health in Europe (2003): Facts & Figures, ERJ~ ~
256   II,     5.  9.  7    |                   Simpson A, Custovic A (2003): Pets and the development
257   II,     5.  9.  7    |                   Verlato G, de Marco R (2003): Is the prevalence of adult
258   II,     5.  9.  7    |                  J Allergy Clin Immunol. 2003 Jun;111(6):1232-8~ ~von
259   II,     5. 10.  1    |                reactions reported (ILSI, 2003). The ranking of most frequently
260   II,     5. 10.  2    |                 allergens (Brusic et al, 2003; Gendel et al, 2006). The
261   II,     5. 10.  2    |                databases. (Brusic et al, 2003).~ ~Table 5.10.1. Available
262   II,     5. 10.  3    |              food in Europe (Gupta et al 2003), it is assumed that their
263   II,     5. 10.  5    |                  by Commission Directive 2003/89/EC (European Commission,
264   II,     5. 10.  5    |                 EC (European Commission, 2003) as regards the indication
265   II,     5. 10.  5    |                  of Commission Directive 2003/89/EC (European Commission,
266   II,     5. 10.  5    |                 EC (European Commission, 2003) specifies a list of food
267   II,     5. 10.  5    |                 labelling.~ ~ ~Directive 2003/89/EC~- Cereals containing
268   II,     5. 10.  5    |            peoples, Commission Directive 2003/89/EC establishes, during
269   II,     5. 10.  7    |                  Gigonzac O, Stelman SJ (2003): Allergen databases. Allergy
270   II,     5. 10.  7    |                     European Commission (2003): Directive 2003/89/EC of
271   II,     5. 10.  7    |             Commission (2003): Directive 2003/89/EC of the European Parliament
272   II,     5. 10.  7    |               and Council of 10 November 2003 amending Directive 2000/
273   II,     5. 10.  7    |              European Union L 308, 25.11.2003, pp. 1518.~htt ~ ~European
274   II,     5. 10.  7    |             Strachan D, Ross Anderson H (2003): Increasing hospital admissions
275   II,     5. 10.  7    |               Sciences Institute (ILSI) (2003): Europe concise monograph
276   II,     5. 11.  3    |             social costs (Dalgard et al, 2003).~Relatively few skin diseases
277   II,     5. 11.  3    |           dermatitis (ACD) (CRF Azevedo, 2003). ACD is characterized by
278   II,     5. 11.  3    |             Jensen et al, 2002). In 2002-2003, the Swedish market showed
279   II,     5. 11.  3    |                  In a study published in 2003, nickel sensitization was
280   II,     5. 11.  3    |                   A Schnuch, and W Uter, 2003). In the USA, where no nickel
281   II,     5. 11.  3    |            Engineering Failure Analysis, 2003;10:255263.~DV Belsito,
282   II,     5. 11.  3    |       interventions, Contact Dermatitis, 2003; 49:107108.~R Silva, F Pere a,
283   II,     5. 11.  3    |           frequent in men (Ceylan et al, 2003).~In Vaud, Switzerland,
284   II,     5. 11.  3    |              countries (Boyle and Smans, 2003).~Both basal cell carcinoma
285   II,     5. 11.  3    |                  rising (De Vries et al, 2003). The net effect is that
286   II,     5. 11.  3    |               Portugal (Boyle and Smans, 2003).~Melanoma is at least to
287   II,     5. 11.  7    |                 5-6.~ ~Boyle P, Smans M (2003): Cancer Mortality Atlas
288   II,     5. 11.  7    |                 Oxford University Press, 2003.~ ~Ceylan C, Ozturk G, Alper
289   II,     5. 11.  7    |             Ceylan C, Ozturk G, Alper S (2003): Non-melanomatous skin
290   II,     5. 11.  7    |              characteristics. J Dermatol 2003;30:123131.~ ~Dalgard F,
291   II,     5. 11.  7    |            Dalgard F, Svensson A, et al (2003): Self-reported skin complaints:
292   II,     5. 11.  7    |        population surveys. Br J Dermatol 2003;149:794-800.~ ~de Rijke
293   II,     5. 11.  7    |                  Coebergh JW, Parkin DM (2003): Changing epidemiology
294   II,     5. 11.  7    |                Scandinavia. Int J Cancer 2003;107:119126.~ ~Diepgen TL,
295   II,     5. 12.  3    |                 al, 2005; Ioannou et al, 2003; Poynard et al, 1999; Sauer
296   II,     5. 12.  7    |           Ioannou G, Doust J, Rockey DC (2003): Terlipressin for acute
297   II,     5. 13        |            culture (European Commission, 2003).~ ~Excess body weight associated
298   II,     5. 14.  1    |          diabetes (Bourgeois and Baehni, 2003).~ ~Recently in Europe,
299   II,     5. 14.  3    |            uncommon condition in France (2003). Most localized forms were
300   II,     5. 14.  8    |          Indicators Development Project. 2003 Report Proceedings. Paris:
301   II,     5. 14.  8    |          Indicators Development Project. 2003 Report Proceedings, eds
302   II,     5. 15.  4    |              January 1999 to 31 December 2003 with the aim of ensuring
303   II,     5. 15.  4    |                  Public Health Programme 2003-2008. The two main lines
304   II,     6.  3.  1    |           sectors other than health. The 2003 SARS outbreak cost some
305   II,     6.  3.  4    |               was higher than during the 200304 season, but lower or
306   II,     6.  3.  4    |                but lower or equal to the 200304 season in the other 13
307   II,     6.  3.  4    |               global threat in mid-March 2003 in East Asia. By July 2003,
308   II,     6.  3.  4    |               2003 in East Asia. By July 2003, the international spread
309   II,     6.  3.  5    |                increase between 2001 and 2003. The incidence rates were
310   II,     6.  3.  5    |          Netherlands (19992000), Spain (2003), Poland (1998) and Lithuania (
311   II,     6.  3.  7    |        Czech Republic (1997) and France (2003) affecting five and seven
312   II,     6.  3.  7    |              from Sierra Leone (2000 and 2003), one case in the Netherlands
313   II,     7.  3        |                Union, Statistics summary 20032005” (see KfV, 2007)1.
314   II,     7.  3        |             years, mostly for the period 2003-2005.~ ~
315   II,     7.  3.  2    |          throughout the EU. Based on the 2003-2005 figures for all ages,
316   II,     7.  3.  3    |        discharges due to injuries, EU27, 2003-2005~ ~On average about
317   II,     7.  4.  4    |                the time of injury, EU27, 2003-2005~ ~The “sport injuries”
318   II,     7.  4.  4    |                  of injury by age group, 2003-2005~ ~Physical exercise
319   II,     7.  7        |                PT, SI, SE (2004) EE, IT (2003) [https://www.unav.es/preventiva/
320   II,     7.  7        |                IT, FI. 3 year average of 2003-2005. [https://webgate.ec.
321   II,     7.  7        |               Union - Statistics Summary 2003-2005. Vienna: Austrian Road
322   II,     8.  1.  3    |          occupational achievements.~ ~In 2003 the proportion of men in
323   II,     8.  1.  5    |               adopted on 30th of October 2003 a Communication regarding
324   II,     8.  1.  5    |                 People with Disabilities 2003. This Communication on "
325   II,     8.  1.  5(5) |                                      COM(2003)650 http ml~
326   II,     8.  2.  1    |                between the years 2000 to 2003. The scope of the surveys
327   II,     8.  2.  1    |                  of 1.1% (Heikura et al, 2003). A similar prevalence of
328   II,     8.  2.  1    |        impairments (Arvio and Sillanpää, 2003).~ ~In Aarhus (Denmark)
329   II,     8.  2.  1    |               295-304.~Kramers, P.G.N., (2003). The ECHI project: Health
330   II,     8.  2.  1    |       Schrojenstein Lantman-de Valk HMJ (2003): Health indicators for
331   II,     8.  2.  2    |            visual impairment proposed in 2003 by a WHO consultation on
332   II,     8.  2.  2    |                  better than 3/60) (WHO, 2003). Blindness is defined as
333   II,     8.  2.  2    |             document WHO/PBL/00.77.~WHO (2003): Prevention of blindness
334   II,     8.  2.  2    |        functioning. Geneva 4-5 September 2003. Document WHO/PBL/03.91~
335   II,     8.  2.  3    |               features in Mathers et al, 2003). In Europe, surveys have
336   II,     8.  2.  3    |                  Johansson and Arlinger, 2003; Karlsmose et al, 1999;
337   II,     8.  2.  3    |                 severity (Mathers et al, 2003). The results obtained are
338   II,     8.  2.  3    |                  Johansson and Arlinger, 2003) showed that 16.9% subjects
339   II,     8.  2.  3    |                  belong) (Mathers et al, 2003).~The burden of disability
340   II,     8.  2.  3    |              Johansson MSK, Arlinger SD (2003): Prevalence of hearing
341   II,     8.  2.  3    |               International J Audiology. 2003;42:18-28~ ~Karlsmose B,
342   II,     8.  2.  3    |            Mathers C, Smith A, Concha M (2003): Global burden of hearing
343   II,     9            |                 pregnancies (Kahn et al, 2003; Luke and Brown, 2007b;
344   II,     9            |                 1997; Dolk and Vrijheid, 2003; EUROCAT, 2004). To protect
345   II,     9            |            mothers (European Commission, 2003). Poor health behaviour
346   II,     9            |              sexes (European Commission, 2003). In conducting the research
347   II,     9            |              replacement therapy (Beral, 2003), and higher body mass index (
348   II,     9            |                 Source: Pomerleau et al, 2003: p. 455~ ~Levels of physical activity
349   II,     9.  1        |            perinatal origin (Cans et al, 2003). Maternal deaths occur
350   II,     9.  1.  1    |               and Norway (Zeitlin et al, 2003). The resulting EURO-PERISTAT
351   II,     9.  1.  1    |                  M, Vutuc C, Lindmark G (2003): Maternal health outcomes
352   II,     9.  1.  1    |               Obstet Gynecol Reprod Biol 2003;111 Suppl 1:S78-87.~ ~Alran
353   II,     9.  1.  1    |            Barros H, Wagener Y, Prati S (2003): Characteristics of the
354   II,     9.  1.  1    |               Obstet Gynecol Reprod Biol 2003;111 Suppl 1:S45-52.~ ~Cans
355   II,     9.  1.  1    |        Fauconnier J, Rambaud P, Jouk PS (2003): Disabilities and trends
356   II,     9.  1.  1    |                  1980-91. Arch Dis Child 2003;88(2):114-7.~Canterino JC,
357   II,     9.  1.  1    |     Cleary-Goldman J, D'Alton ME, et al (2003): Prospective risk of fetal
358   II,     9.  1.  1    |                 practice. Obstet Gynecol 2003;102(4):685-92.~Kaminski
359   II,     9.  1.  1    |              Barros H, Blondel B, et al (2003): Selecting an indicator
360   II,     9.  1.  1    |               Obstet Gynecol Reprod Biol 2003;111 Suppl 1:S5-S14.~ ~
361   II,     9.  1.  2    |                 pregnancies (Kahn et al, 2003; Luke and Brown, 2007b;
362   II,     9.  1.  2    |                 1997; Dolk and Vrijheid, 2003; EUROCAT, 2004). To protect
363   II,     9.  1.  2    |            Barros H, Wagener Y, Prati S (2003): Characteristics of the
364   II,     9.  1.  2    |                 402.~Dolk H, Vrijheid M (2003): "The Impact of Environmental
365   II,     9.  2.  2    |               Köhler, 2002; Rigby et al, 2003). This was charged with
366   II,     9.  2.  3    |            Finland (European Commission, 2003), although in November 2006
367   II,     9.  2.  4    |            mothers (European Commission, 2003). Poor health behaviour
368   II,     9.  2.  4    |              sexes (European Commission, 2003). In conducting the research
369   II,     9.  2.  5    |               Programme in Public Health 2003-2008 (European Parliament
370   II,     9.  2.  7    |              2000~ ~European Commission (2003): The Health Status of the
371   II,     9.  2.  7    |                  field of public health (2003-2008), OJ No L 271, 9 October
372   II,     9.  3.  1    |             across Europe (White & Cash, 2003) and there have been to
373   II,     9.  3.  1    |               Health Forum (White & Cash 2003).~ ~There are also difficulties
374   II,     9.  3.  1    |              lost) (European Commission, 2003). These accidents are estimated
375   II,     9.  3.  1    |              people (European Commission 2003). The disease usually first
376   II,     9.  3.  1    |                  1 000 inhabitants. In a 2003 report, the European Commission
377   II,     9.  3.  1    |                20% (European Commission, 2003). Hypertension is both a
378   II,     9.  3.  1    |                 65 (European Commission, 2003). For both sexes of all
379   II,     9.  3.  1    |       respectively (European Commission, 2003).~ ~Peripheral vascular
380   II,     9.  3.  1    |             Greece (European Commission, 2003). The Netherlands report
381   II,     9.  3.  1    |              that posed by smoking (WHO, 2003).~ ~The Obesity in Europe
382   II,     9.  3.  1    |             Europe (European Commission, 2003). The two main transmission
383   II,     9.  3.  1    |              AIDS) (European Commission, 2003), but 24,184 newly diagnosed
384   II,     9.  3.  1    |                gender inequality (Brown, 2003). UNAIDS has observed that
385   II,     9.  3.  1    |         disability (European Commission, 2003).~ ~Menopause~ ~Climateric.
386   II,     9.  3.  1    |          previously thought (Boyle et al 2003). The causes are mainly
387   II,     9.  3.  1    |              replacement therapy (Beral, 2003), and higher body mass index (
388   II,     9.  3.  1    |                 Source: Pomerleau et al, 2003: p. 455~ ~Levels of physical activity
389   II,     9.  3.  1    |                 1): p. 50-56.~ ~Beral V (2003): Breast cancer and hormone-replacement
390   II,     9.  3.  1    |                  the UrEpik Study Group (2003) The prevalence of male
391   II,     9.  3.  1    |                54(5): 328-332~ ~Brown H (2003): Women's Lack of Control
392   II,     9.  3.  1    |              http://www.prb.org/Articles/2003/WomensLackofControlOverSTIRisksDrivesMicrobicideSearch.
393   II,     9.  3.  1    |                     European Commission (2003): The Health Status of the
394   II,     9.  3.  1    |         Community/Europe Against Cancer (2003): European Code Against
395   II,     9.  3.  1    |                  6.~ ~White AK , Cash K (2003): The state of men’s health
396   II,     9.  3.  1    |                Europe. Copenhagen~ ~WHO (2003) Controlling the global
397   II,     9.  3.  2    |              morbidity (Alexander et al, 2003). The causes of maternal
398   II,     9.  3.  2    |                  for the two-year period 2003 and 2004, there is a substantial
399   II,     9.  3.  2    |         feasibility study (Breart et al, 2003). More recent data, collected
400   II,     9.  3.  2    |                  M, Vutuc C, Lindmark G (2003): Maternal health outcomes
401   II,     9.  3.  2    |               Obstet Gynecol Reprod Biol 2003;111 Suppl 1:S78-87.~ ~Alran
402   II,     9.  3.  2    |            Barros H, Wagener Y, Prati S (2003): Characteristics of the
403   II,     9.  3.  2    |               Obstet Gynecol Reprod Biol 2003;111 Suppl 1:S45-52.~ ~Cans
404   II,     9.  3.  2    |        Fauconnier J, Rambaud P, Jouk PS (2003): Disabilities and trends
405   II,     9.  3.  2    |                  1980-91. Arch Dis Child 2003;88(2):114-7.~ ~Canterino
406   II,     9.  3.  2    |     Cleary-Goldman J, D'Alton ME, et al (2003): Prospective risk of fetal
407   II,     9.  3.  2    |                 practice. Obstet Gynecol 2003;102(4):685-92.~ ~Kaminski
408   II,     9.  3.  2    |              Barros H, Blondel B, et al (2003): Selecting an indicator
409   II,     9.  3.  2    |               Obstet Gynecol Reprod Biol 2003;111 Suppl 1:S5-S14.~ ~ ~
410   II,     9.  3.  3    |              STIs/HIV/AIDS (Bajos et al, 2003). The study data are based
411   II,     9.  3.  3    |              Haavio-Mannila and Kontula, 2003; Nikula et al, 2007), Portugal (
412   II,     9.  3.  3    |                UK, at 16.2 (Bajos et al, 2003); the increase in the proportion
413   II,     9.  3.  3    |                  the 1990s (Bajos et al, 2003). At variance, in Ireland
414   II,     9.  3.  3    |                to the ‘80s (Bajos et al, 2003). In all of these Countries,
415   II,     9.  3.  3    |           youngest cohorts (Bajos et al, 2003; Nikula et al, 2007). Also
416   II,     9.  3.  3    |                  stable between 1993 and 2003 at 18 years of age for both
417   II,     9.  3.  3    |                  the 1990s (Bajos et al, 2003). As a consequence of the
418   II,     9.  3.  3    |               has decreased from 1993 to 2003 from about 11 to about 9
419   II,     9.  3.  3    |                 than women (Bajos et al, 2003; Nikula et al, 2007), but
420   II,     9.  3.  3    |                 1998, decreased again in 2003 (Weiss,2008).~ ~It has been
421   II,     9.  3.  3    |              lives (European Parliament, 2003).~ ~Individual-based interventions
422   II,     9.  3.  3    |                  Guillaume A, Kontula O (2003): Reproductive behaviour
423   II,     9.  3.  3    |                 66.~European Parliament (2003): Resolution on sexual and
424   II,     9.  3.  3    |                  Journal C 271 E , 12/11/2003 P. 0369 - 0374~Facultes
425   II,     9.  3.  3    |         Encounter Module Project. May 13 2003. Available at: htt l (accessed
426   II,     9.  3.  3    |             Haavio-Mannila E, Kontula O (2003) Sexual trends in the Baltic
427   II,     9.  3.  3    |              sexual risk in Sweden (1989-2003). Arch Sex Behav 34:219-
428   II,     9.  3.  3    |                 each year 1993, 1998 and 2003.~Wellings K, Nanchahak K,
429   II,     9.  3.  3    |                  births in England, 1994-2003, and the national teenage
430   II,     9.  4.  1    |     sustainability (European Commission, 2003). Research stresses the
431   II,     9.  4.  3    |               rate (European Commission, 2003). The ‘elderly index’ (obtained
432   II,     9.  4.  3    |            disease (European Commission, 2003). The most common causes
433   II,     9.  4.  3    |        Luxembourg) (European Commission, 2003). The highest rates of suicide
434   II,     9.  4.  3    |             European Health Men’s Forum, 2003). Morbidity for Coronary
435   II,     9.  4.  3    |             European Health Men’s Forum, 2003).~ ~Stroke. Recurrent strokes
436   II,     9.  4.  3    |       International Diabetes Federation, 2003). Long-term complications
437   II,     9.  4.  3    |                age) (DECODE Study Group, 2003). In 70 to 79 year olds,
438   II,     9.  4.  3    |                  cases, between 1995 and 2003, whilst cases of gonorrhoea
439   II,     9.  4.  3    |                 249%, from 39 to 136. In 2003, women over 40 made up 7%
440   II,     9.  4.  3    |           susceptibility to STIs (Mahar, 2003).~ ~ ~Daily life-limiting
441   II,     9.  4.  5    |           children (European Commission, 2003).~ ~Acute Geriatric Medicine.
442   II,     9.  4.  5    |               was adopted on 20 February 2003 (6528/03). The replies from
443   II,     9.  4.  5    |               come into force in January 2003, will be usefule for developing
444   II,     9.  4.  7    |             Diabetes Epidemiology Group (2003): Is the current definition
445   II,     9.  4.  7    | non-cardiovascular disease?Diabetes Care 2003;26:688-696.~ ~EPHA briefing
446   II,     9.  4.  7    |                     European Commission (2003): The Health Status of the
447   II,     9.  4.  7    |             European Men’s Health Forum (2003): A report on the state
448   II,     9.  4.  7    |       International Diabetes Federation (2003): World Diabetes Day. United
449   II,     9.  4.  7    |                   3(3):94-98~ ~Mahar, F (2003): Sexually transmitted infections
450   II,     9.  4.  7    |             Volume 9, Number 4, December 2003 , pp. 173-174(2)~ ~Mukaetova-Ladinska
451   II,     9.  4.  7    |                  Health Programme~ ~WHO (2003): Atlas of Health in Europe~ ~
452   II,     9.  5.  3    |          percentage of the labour force, 2003~ ~In most countries, the
453   II,     9.  5.  3    |          allergies (European Commission, 2003). By contrast, males suffer
454   II,     9.  5.  3    |            mothers (European Commission, 2003). Education is also significantly
455   II,     9.  5.  3    |               upper secondary education (2003)~ ~Poverty in old age~ ~
456   II,     9.  5.  3    |                 Metropolitan University, 2003 ~ ~ ~ ~B. Information of
457   II,     9.  5.  3    |               Spain, 2002; b Joni Sager, 2003; c Women’s issues Information
458   II,     9.  5.  3    |              replacement therapy (Beral, 2003), and higher body mass index (
459   II,     9.  5.  3    |                 Smoking in 1985 and 2002-2003~ ~The issues around quitting
460   II,     9.  5.  3    |            culture (European Commission, 2003).~ ~It is more commonly
461   II,     9.  5.  3    |               male and female (Paechter, 2003).~ ~Feelings of dissatisfaction
462   II,     9.  5.  4    |         information is essential (Brown, 2003). Most effective however,
463   II,     9.  5.  4    |               screening guidelines (COM (2003) 0230, Proposal for a Council
464   II,     9.  5.  6    |               RoutledgeFalmer.~ ~Beral V 2003: Breast cancer and hormone-replacement
465   II,     9.  5.  6    |                  of Education~ ~Brown H (2003): Women's Lack of Control
466   II,     9.  5.  6    |              http://www.prb.org/Articles/2003/WomensLackofControlOverSTIRisksDrivesMicrobicideSearch.
467   II,     9.  5.  6    |                Christen AG, Christen JA (2003): The female smoker: from
468   II,     9.  5.  6    |               Safety and Health at Work (2003): Gender issues in safety
469   II,     9.  5.  6    |        Luxembourg~ ~European Commission (2003): The Health Status of the
470   II,     9.  5.  6    |        Commission/Europe Against Cancer (2003): European Code Against
471   II,     9.  5.  6    |                  16.07.07)~ ~Paechter C (2003): Power, Bodies and Identity:
472  III,    10.  1.  1    |            Titchenal, 1988; Tappy et al, 2003). The type, intensity, frequency
473  III,    10.  1.  1    |          exercise on diet. (Tappy et al, 2003) Within the normal activity
474  III,    10.  1.  1    |              influential (Gmel and Rehm, 2003; Milgram, 1993; Taylor and
475  III,    10.  1.  3    |               2581-2590.~Gmel G, Rehm J (2003): Harmful alcohol use. Alcohol
476  III,    10.  1.  3    |                 Binnert C, Schneiter Ph (2003): Energy expenditure, physical activity
477  III,    10.  2.  1    |                 smoking between 2000 and 2003, while Belgium recorded
478  III,    10.  2.  1    |                     European Commission, 2003).~In 19901994, the self-reported
479  III,    10.  2.  1    |                  14 hours per day (ENSP, 2003).~ ~Health impact of smokeless
480  III,    10.  2.  1    |              unequivocally clear. (ENSP, 2003).~ ~
481  III,    10.  2.  1    |           legalizing snuff (Bates et al, 2003).~The critics of this approach
482  III,    10.  2.  1    |                 and Gilmore, 2007; ENSP, 2003). The Swedish experience
483  III,    10.  2.  1    |         attributed to the success of the 2003 EU directive banning tobacco
484  III,    10.  2.  1    |                   McNeill A, Ramström L (2003): European Union policy
485  III,    10.  2.  1    |                Zatonski W, zur Hausen H (2003): European Code Against
486  III,    10.  2.  1    |            justification: third version (2003). Annals of Oncology; 14:
487  III,    10.  2.  1    |                     European Commission (2003): European Opinion Research
488  III,    10.  2.  1    |               and the Environment (EEIG, 2003): Actions and Attitudes.
489  III,    10.  2.  1    |         Attitudes. Special Eurobarometer 2003; 183. Available at:~htt ~ ~
490  III,    10.  2.  1    |               Smoking Prevention (ENSP) (2003): Status Report on Oral
491  III,    10.  2.  1    |          remained the same in 2006 as in 2003 (10%). However, given that
492  III,    10.  2.  1    |                  2006 compared to 61% in 2003, the actual number of EU15
493  III,    10.  2.  1    |                 increased by 10% between 2003 and 2006.~ ~Nearly all (
494  III,    10.  2.  1    |              years of age. Data from the 2003 European School Survey Project
495  III,    10.  2.  1    |            Europe per cost element (year 2003)~ ~
496  III,    10.  2.  1    |            advocacy groups (Babor et al, 2003). In the context of public
497  III,    10.  2.  1    |            assault injuries (Giesbrecht, 2003). Community mobilization
498  III,    10.  2.  1    |                  Safety Action Programme 2003-2010~http ~ ~European Commission
499  III,    10.  2.  1    |                  Public Health Programme 2003-2008:~ ~PHEPA: Primary Health
500  III,    10.  2.  1    |                  J, Room R and Rossow I (2003): Alcohol: No Ordinary Commodity.